Transcat (NASDAQ:TRNS) Sets New 52-Week High – Time to Buy?

Shares of Transcat, Inc. (NASDAQ:TRNS) hit a new 52-week high during mid-day trading on Friday . The stock traded as high as $96.60 and last traded at $95.4620, with a volume of 34541 shares trading hands. The stock had previously closed at $94.54.

Key Stories Impacting Transcat

Here are the key news stories impacting Transcat this week:

• Positive Sentiment: Transcat’s Service segment remains a growth driver, with management targeting high-single-digit organic growth while expanding its operational-excellence initiatives. Transcat targets high single-digit Service organic growth as operational excellence focus expands
• Positive Sentiment: The company’s latest quarterly results exceeded expectations, with EPS of $0.51 versus the $0.38 consensus estimate and revenue of $92.95 million compared with expectations of $86.55 million. However, margin pressures remain, particularly despite the Service segment’s growth. TRNS Q2 deep dive: Service segment drives growth, margin pressures persist
• Neutral Sentiment: Northland Securities lowered its rating on TRNS to “Market Perform” and maintained a $95 price target, roughly in line with the stock’s recent trading level. Transcat Rating Lowered to Market Perform at Northland Securities
• Negative Sentiment: Northland cut EPS forecasts across multiple periods: Q3 2027 to $0.20 from $0.38, FY2027 to $1.71 from $1.86, FY2028 to $2.12 from $2.33, FY2029 to $2.58 from $3.18, and FY2030 to $3.01 from $3.51. It also reduced Q2 2027, Q4 2027 and FY2031 estimates. These revisions signal weaker expected earnings momentum and are the main pressure on the shares.

Analyst Ratings Changes

Several research analysts recently weighed in on the company. Zacks Research upgraded Transcat from a “strong sell” rating to a “hold” rating in a research report on Friday, May 15th. Weiss Ratings upgraded Transcat from a “sell (d)” rating to a “sell (d+)” rating in a research report on Thursday, May 28th. Northland Securities lowered shares of Transcat from an “outperform” rating to a “market perform” rating and set a $95.00 target price for the company. in a report on Wednesday. Finally, Wall Street Zen upgraded shares of Transcat from a “sell” rating to a “hold” rating in a research note on Sunday, June 28th. One analyst has rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $105.50.

Transcat Price Performance

The company has a current ratio of 2.49, a quick ratio of 1.99 and a debt-to-equity ratio of 0.36. The stock has a market capitalization of $884.94 million, a price-to-earnings ratio of 257.72 and a beta of 0.68. The stock has a 50-day moving average price of $89.42 and a 200 day moving average price of $79.52.

Transcat (NASDAQ:TRNS) last announced its earnings results on Tuesday, August 4th. The scientific and technical instruments company reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.13. Transcat had a return on equity of 5.56% and a net margin of 0.99%.The business had revenue of $92.95 million during the quarter, compared to the consensus estimate of $86.55 million. As a group, equities research analysts expect that Transcat, Inc. will post 1.63 earnings per share for the current year.

Institutional Investors Weigh In On Transcat

Hedge funds have recently modified their holdings of the company. Vanguard Group Inc. raised its stake in Transcat by 0.4% during the third quarter. Vanguard Group Inc. now owns 530,771 shares of the scientific and technical instruments company’s stock worth $38,852,000 after purchasing an additional 2,041 shares during the period. Royce & Associates LP grew its stake in shares of Transcat by 15.3% in the 4th quarter. Royce & Associates LP now owns 390,546 shares of the scientific and technical instruments company’s stock valued at $22,156,000 after buying an additional 51,774 shares during the period. Dimensional Fund Advisors LP grew its stake in shares of Transcat by 3.7% in the 1st quarter. Dimensional Fund Advisors LP now owns 262,033 shares of the scientific and technical instruments company’s stock valued at $19,244,000 after buying an additional 9,266 shares during the period. Wellington Management Group LLP increased its holdings in shares of Transcat by 677.7% during the 4th quarter. Wellington Management Group LLP now owns 248,539 shares of the scientific and technical instruments company’s stock worth $14,100,000 after buying an additional 216,579 shares during the last quarter. Finally, Bamco Inc. NY increased its holdings in shares of Transcat by 6.2% during the 4th quarter. Bamco Inc. NY now owns 203,477 shares of the scientific and technical instruments company’s stock worth $11,543,000 after buying an additional 11,911 shares during the last quarter. Hedge funds and other institutional investors own 98.34% of the company’s stock.

Transcat Company Profile

Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.